Rotavirus Clinical Trials Rotavirus RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Safety Study of 2 Formulations of GlaxoSmithKline Biologicals' (GSK's) Human Rotavirus (HRV) Vaccine in Healthy Infants of Age 6-12 Weeks
Condition:   Infections, Rotavirus Interventions:   Biological: HRV Liquid;   Biological: HRV Lyophilized Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2019 Category: Research Source Type: clinical trials